Company Expands with Investment in Medicinal Psychedelic Market and Trip into the Metaverse

Company Expands with Investment in Medicinal Psychedelic Market and Trip into the Metaverse

By: Tomas Ronolski - AllPennyStocks.com News

Monday, March 21, 2022

With an expected growth rate of 9.4 percent through 2026, the medicinal mushroom market is a booming industry that is addressing global mental health needs.

Biopharma company Mycotopia Therapies Inc. (OTC Pink: TPIA) announced it entered the $13 billion medicinal mushroom market with HAVN Life Sciences' Biopharmaceuticals and Ei.Ventures MANA Products. Through the expanded agreement, Mycotopia will have access to  HAVN Life’s functional mushrooms and the white label supply and distribution of HAVN’s line of natural OTC health products.

The firms are moving forward to form PSLY.COM, which is also the name of the recently acquired 12x 12 estate in The Sandbox metaverse.

Shares of Mycotopia closed Friday up over 9 percent at $3.00.


Copyright © 2022 AllPennyStocks.com. All rights reserved. Republication or redistribution of AllPennyStocks.com's content is expressly prohibited without the prior written consent of AllPennyStocks.com. AllPennyStocks.com shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Other Penny Stock Movers

Shares of Biopharma Up After News of Uplisting
Fed’s Preferred Inflation Measure Cements Higher for Longer
Expansion into Taiwan Markets Is Helping Shares of this Blockchain Firm
Most Popular
FREE Newsletter


Back to Top